Principal Investigators

    Peter Andersen


    Umeå University

    Contact information of lead PI



    Title of project or programme

    Genetic factors causing sporadic and familial amyotrophic lateral sclerosis (ALS/MND) with or without frontotemporal dementia.

    Source of funding information

    Swedish Research Council

    Total sum awarded (Euro)

    € 544,070

    Start date of award


    Total duration of award in years


    The project/programme is most relevant to:

    Motor neurone diseases


    Research Abstract

    ALS is a fatal neurodegenerative syndrome characterized by progressive loss of motorneurons in the brain and spinal cord resulting in paralysis and death. 230 cases are diagnosed annually in Sweden. 10% have a dominantly Mendelian-inherited family history of ALS and 15 genes have been identified, most common are mutations in SOD1 and the recently found C9ORF72 with a GGGGCC-repeat expansion. Since 1993, 167 SOD1 mutations have been found, 43 by us and 18 in Nordic ALS cases. 6% of ALS cases have a SOD1 mutation. The D90A is the only SOD1 mutation inherited as a recessive trait and causes an unique type of ALS with long survival suggesting that D90A patients have co-inherited a modifying protective gene which is absent in other mutants. Our objectives are to find the D90A-modifying factor, to study the prevalence of C9ORF72-repeat expansions in patients with ALS, ALS+FTD, and FTD, characterize the phenotype and penetrance for patients with different sizes of C9ORF72 expansions in blood and autopsy tissue specimens from different parts of the CNS. Our southern blot results shows ALS patients to have >800 repeats but <1600, while most controls <<30. We have found a few controls with intermediate expansions and two patients with homozygous expansions. Comparative SOD1 and C9ORF72 expressions studies will be performed in fibroblasts cultures established from patients with C9ORF72, SOD1, FUS, NF-H, VAPB and Alsin mutations, and in vitro antisense studies performed.

    Lay Summary

    Further information available at:

Types: Investments > €500k
Member States: Sweden
Diseases: Motor neurone diseases
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF